The role of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor dry eye disease (DED), 2) to identify those most appropriate to fulfil the definition of DED and its sub-classifications, 3) to propose the most appropriate order and technique to conduct these tests in a clinical setting, and 4) to provide a differential diagnosis for DED and distinguish conditions where DED is a comorbidity. Prior to diagnosis, it is important to exclude conditions that can mimic DED with the aid of triaging questions. Symptom screening with the DEQ-5 or OSDI confirms that a patient might have DED and triggers the conduct of diagnostic tests of (ideally non-invasive) breakup time, osmolarity and ocular surface staining with fluorescein and lissamine green (observing the cornea, conjunctiva and eyelid margin). Meibomian gland dysfunction, lipid thickness/dynamics and tear volume assessment and their severity allow sub-classification of DED (as predominantly evaporative or aqueous deficient) which informs the management of DED. Videos of these diagnostic and sub-classification techniques are available on the TFOS website. It is envisaged that the identification of the key tests to diagnose and monitor DED and its sub-classifications will inform future epidemiological studies and management clinical trials, improving comparability, and enabling identification of the sub-classification of DED in which different management strategies are most efficacious.
Abstract
Journal Article
Review
eng
28736342
Wolffsohn, James S., et al. "TFOS DEWS II Diagnostic Methodology Report." The Ocular Surface, vol. 15, no. 3, 2017, pp. 539-574.
Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15(3):539-574.
Wolffsohn, J. S., Arita, R., Chalmers, R., Djalilian, A., Dogru, M., Dumbleton, K., Gupta, P. K., Karpecki, P., Lazreg, S., Pult, H., Sullivan, B. D., Tomlinson, A., Tong, L., Villani, E., Yoon, K. C., Jones, L., & Craig, J. P. (2017). TFOS DEWS II Diagnostic Methodology report. The Ocular Surface, 15(3), 539-574. https://doi.org/10.1016/j.jtos.2017.05.001
Wolffsohn JS, et al. TFOS DEWS II Diagnostic Methodology Report. Ocul Surf. 2017;15(3):539-574. PubMed PMID: 28736342.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - TFOS DEWS II Diagnostic Methodology report.
AU - Wolffsohn,James S,
AU - Arita,Reiko,
AU - Chalmers,Robin,
AU - Djalilian,Ali,
AU - Dogru,Murat,
AU - Dumbleton,Kathy,
AU - Gupta,Preeya K,
AU - Karpecki,Paul,
AU - Lazreg,Sihem,
AU - Pult,Heiko,
AU - Sullivan,Benjamin D,
AU - Tomlinson,Alan,
AU - Tong,Louis,
AU - Villani,Edoardo,
AU - Yoon,Kyung Chul,
AU - Jones,Lyndon,
AU - Craig,Jennifer P,
Y1 - 2017/07/20/
PY - 2017/04/29/received
PY - 2017/05/01/accepted
PY - 2017/7/25/pubmed
PY - 2018/5/15/medline
PY - 2017/7/25/entrez
KW - DEWS
KW - Diagnosis
KW - Dry Eye Workshop
KW - Dry eye disease (DED)
KW - Methodology
KW - Monitoring
KW - Questionnaires
KW - Sub-classification of dry eye
KW - Tests for dry eye
SP - 539
EP - 574
JF - The ocular surface
JO - Ocul Surf
VL - 15
IS - 3
N2 - The role of the Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II Diagnostic Methodology Subcommittee was 1) to identify tests used to diagnose and monitor dry eye disease (DED), 2) to identify those most appropriate to fulfil the definition of DED and its sub-classifications, 3) to propose the most appropriate order and technique to conduct these tests in a clinical setting, and 4) to provide a differential diagnosis for DED and distinguish conditions where DED is a comorbidity. Prior to diagnosis, it is important to exclude conditions that can mimic DED with the aid of triaging questions. Symptom screening with the DEQ-5 or OSDI confirms that a patient might have DED and triggers the conduct of diagnostic tests of (ideally non-invasive) breakup time, osmolarity and ocular surface staining with fluorescein and lissamine green (observing the cornea, conjunctiva and eyelid margin). Meibomian gland dysfunction, lipid thickness/dynamics and tear volume assessment and their severity allow sub-classification of DED (as predominantly evaporative or aqueous deficient) which informs the management of DED. Videos of these diagnostic and sub-classification techniques are available on the TFOS website. It is envisaged that the identification of the key tests to diagnose and monitor DED and its sub-classifications will inform future epidemiological studies and management clinical trials, improving comparability, and enabling identification of the sub-classification of DED in which different management strategies are most efficacious.
SN - 1937-5913
UR - https://www.unboundmedicine.com/prime/citation/28736342/TFOS_DEWS_II_Diagnostic_Methodology_report_
DB - PRIME
DP - Unbound Medicine
ER -


